Patients With a Large Prostate Show a Higher Prevalence of Androgenetic Alopecia

    September 2005 in “ Archives of Dermatological Research ”
    WenChieh Chen, Chao Yang, Guan-Yu Chen, Meng Wu, Hamm Ming Sheu, Tzong-Shin Tzai
    Image of study
    TLDR Large prostate patients more likely to have hair loss.
    The study found that patients with a large prostate have a higher prevalence of androgenetic alopecia. The study defined BPH as having a prostate volume greater than 30 cm³, a maximal urine flow rate less than 15 ml/s, and a mean urine flow rate less than 10 ml/s, and a prostate-specific antigen less than 10 ng/ml. The study was conducted by researchers from various departments in Taiwan.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community 4 months progress / dut 0.5mg + topical min

      in Progress Pictures  108 upvotes 2 years ago
      The conversation is about someone's 4-month hair regrowth progress using 0.5mg dutasteride and topical minoxidil. Another person is inspired and is using 5mg finasteride and 5% minoxidil topically twice daily, hoping for similar results.

      community Dermatologist told me to quit fin after turning 40

      in Finasteride/Dutasteride  194 upvotes 2 years ago
      A dermatologist advised a patient to stop taking finasteride (fin) after turning 40 due to potential risk of aggressive prostate cancer. The patient and others in the conversation debated this advice, discussing the relationship between finasteride, prostate cancer, and hair loss, and considering alternatives like topical finasteride.

      community Testosterone and Estradiol levels on 1 mg/day dutasteride

      in Finasteride/Dutasteride  43 upvotes 5 months ago
      A 30-year-old man experienced significant hair regrowth and improved libido after using finasteride and dutasteride for androgenetic alopecia, with no adverse effects. He plans to reduce dutasteride dosage when trying to conceive and has been using topical minoxidil since 2015.

      community Binding affinity of pyrilutamide!

      in Update  170 upvotes 3 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Anyone else growing tired of the finasteride wars?

      in Finasteride/Dutasteride  169 upvotes 2 years ago
      The conversation is about differing experiences with finasteride for hair loss, with some users reporting side effects and others not, and the debate over the drug's safety and effectiveness. Specific treatments mentioned include finasteride, dutasteride, and topical finasteride.

    Similar Research

    5 / 1000+ results